Prelude Therapeutics Inc (NAS:PRLD)
$ 3.62 -0.11 (-2.95%) Market Cap: 198.84 Mil Enterprise Value: 14.56 Mil PE Ratio: 0 PB Ratio: 0.94 GF Score: 38/100